Proarrhythmic effects of aldosterone during myocardial ischemia- reperfusion: Implication of the sarcolemmal-KATP channels

Journal of Cardiovascular Pharmacology

Volumn 64, Issue 2, 2014, Pages 134-141

  Alexandre, Joachim ^a,b   Puddu, Paolo Emilio ^c   Simard, Christophe ^b   Hof, Thomas ^b   Sallé, Laurent ^b,d   Guinamard, Romain ^b,d   Manrique, Alain ^b,d   Rouet, René ^b,d   Beygui, Farzin ^a,d   Milliez, Paul ^a,b,d  

^a CAEN UNIVERSITY HOSPITAL   (France)

^b France   (France)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITÉ DE CAEN   (France)

Author keywords

antiarrhythmia agents; ischemia; renin angiotensin system; reperfusion; ventricular myocardium

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; ALDOSTERONE; BENZOPYRAN DERIVATIVE; BIMAKALIM; DIHYDROPYRIDINE DERIVATIVE; GLIBENCLAMIDE;

ACTION POTENTIAL; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; DISEASE MODEL; DRUG EFFECTS; FEMALE; HEART VENTRICLE; IN VITRO STUDY; MALE; METABOLISM; PATHOPHYSIOLOGY; PERFUSION; RABBIT; REPERFUSION INJURY; SARCOLEMMA;

ACTION POTENTIALS; ALDOSTERONE; ANIMALS; BENZOPYRANS; DIHYDROPYRIDINES; DISEASE MODELS, ANIMAL; FEMALE; GLYBURIDE; HEART VENTRICLES; IN VITRO TECHNIQUES; KATP CHANNELS; MALE; MYOCARDIAL REPERFUSION INJURY; PERFUSION; RABBITS; SARCOLEMMA;

EID: 84906047133     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0000000000000097     Document Type: Article

References (37)

1. Mehta RH, Starr AZ, Lopes RD, et al. Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention. JAMA. 2009;301:1779-1789.
2. Milliez P, Girerd X, Plouin P-F, et al. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol. 2005;45:1243-1248. (Pubitemid 40523144)
3. Beygui F, Collet J-P, Benoliel J-J, et al. High plasma aldosterone levels on admission are associated with death in patients presenting with acute ST-elevation myocardial infarction. Circulation. 2006;114:2604-2610. (Pubitemid 44967343)
4. Sigurdsson A, Held P, Swedberg K. Short-and long-term neurohormonal activation following acute myocardial infarction. Am Heart J. 1993;126: 1068-1076. (Pubitemid 23330405)
5. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999;341:709-717. (Pubitemid 29407370)
6. Pitt B, Remme W, Zannad F, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 2003;348:1309-1321. (Pubitemid 36384098)
7. Beygui F, Labbé J-P, Cayla G, et al. Early mineralocorticoid receptor blockade in primary percutaneous coronary intervention for ST-elevation myocardial infarction is associated with a reduction of life-threatening ventricular arrhythmia. Int J Cardiol. 2013;167:73-79.
8. Nichols CG, Singh GK, Grange DK. KATP channels and cardiovascular disease: Suddenly a syndrome. Circ Res. 2013;112:1059-1072.
9. Zünkler BJ. Human ether-a-go-go-related (HERG) gene and ATPsensitive potassium channels as targets for adverse drug effects. Pharmacol Ther. 2006;112:12-37. (Pubitemid 44339547)
10. Janse MJ, Cinca J, Moréna H, et al. The "border zone" in myocardial ischemia. An electrophysiological, metabolic, and histochemical correlation in the pig heart. Circ Res. 1979;44:576-588. (Pubitemid 9170889)
11. Alexandre J, Rouet R, Puddu P-E, et al. Dronedarone versus amiodarone in preventing premature ventricular contractions in an in vitro model of "border zone." J Cardiovasc Pharmacol. 2014;63:49-57.
12. Alexandre J, Schiariti M, Rouet R, et al. Rabbit ventricular myocardium undergoing simulated ischemia and reperfusion in a double compartment tissue bath: A model to investigate both antiarrhythmic and arrhythmogenic likelihood. Int J Physiol Pathophysiol Pharmacol. 2013;5:52-60.
13. Puddu PE, Garlid KD, Monti F, et al. Bimakalim: A promising KATP channel activating agent. Cardiovasc Drug Rev. 2000;18:25-46. (Pubitemid 30346769)
14. Boixel C, Gavillet B, Rougier J-S, et al. Aldosterone increases voltagegated sodium current in ventricular myocytes. Am J Physiol Heart Circ Physiol. 2006;290:H2257-H2266. (Pubitemid 43846052)
15. Cole WC, McPherson CD, Sontag D. ATP-regulated K+ channels protect the myocardium against ischemia/reperfusion damage. Circ Res. 1991; 69:571-581.
16. Tamargo J, Caballero R, Gómez R, et al. Pharmacology of cardiac potassium channels. Cardiovasc Res. 2004;62:9-33. (Pubitemid 38326808)
17. Quinlan CL, Costa ADT, Costa CL, et al. Conditioning the heart induces formation of signalosomes that interact with mitochondria to open mito-KATP channels. Am J Physiol Heart Circ Physiol. 2008;295:H953-H961.
18. Garlid KD, Puddu PE, Pasdois P, et al. Inhibition of cardiac contractility by 5-hydroxydecanoate and tetraphenylphosphonium ion: A possible role of mitoKATP in response to inotropic stress. Am J Physiol Heart Circ Physiol. 2006;291:H152-H160.
19. Findlay I. Inhibition of ATP-sensitive K+ channels in cardiac muscle by the sulphonylurea drug glibenclamide. J Pharmacol Exp Ther. 1992;261: 540-545.
20. Tominaga M, Horie M, Okada Y. Additional similarity of cardiac cAMPactivated Cl2 channels to CFTR Cl2 channels. Jpn J Physiol. 1994;44 (suppl 2):S215-S218.
21. Lee S-Y, Lee CO. Inhibition of Na+-K+ pump and L-type Ca2+ channel by glibenclamide in guinea pig ventricular myocytes. J Pharmacol Exp Ther. 2005;312:61-68. (Pubitemid 40096453)
22. Demion M, Guinamard R, El Chemaly A, et al. An outwardly rectifying chloride channel in human atrial cardiomyocytes. J Cardiovasc Electrophysiol. 2006;17:60-68.
23. Guinamard R, Demion M, Magaud C, et al. Functional expression of the TRPM4 cationic current in ventricular cardiomyocytes from spontaneously hypertensive rats. Hypertension. 2006;48:587-594. (Pubitemid 44843860)
24. Babes A, Fischer MJM, Filipovic M, et al. The anti-diabetic drug glibenclamide is an agonist of the transient receptor potential Ankyrin 1 (TRPA1) ion channel. Eur J Pharmacol. 2013;704:15-22.
25. Kunert-Keil C, Bisping F, Krüger J, et al. Tissue-specific expression of TRP channel genes in the mouse and its variation in three different mouse strains. BMC Genomics. 2006;7:159.
26. Urbach V, Kerkhove EV, Maguire D, et al. Rapid activation of KATP channels by aldosterone in principal cells of frog skin. J Physiol. 1996; 491:111-120.
27. De Giusti VC, Nolly MB, Yeves AM, et al. Aldosterone stimulates the cardiac Na(+)/H(+) exchanger via transactivation of the epidermal growth factor receptor. Hypertension. 2011;58:912-919.
28. Miki T, Seino S. Roles of KATP channels as metabolic sensors in acute metabolic changes. J Mol Cell Cardiol. 2005;38:917-925. (Pubitemid 40725939)
29. Sato T, Shigematsu S, Arita M. Mexiletine-induced shortening of the action potential duration of ventricular muscles by activation of ATPsensitive K+ channels. Br J Pharmacol. 1995;115:381-382.
30. Picard S, Rouet R, Duval D, et al. KATP channel modulators and myocardial damages induced by ischemia-reperfusion: Membrane lipids injury and arrhythmias. J Mol Cell Cardiol. 1998;30: 2613-2621. (Pubitemid 29017502)
31. Oliver MF, Opie LH. Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet. 1994;343:155-158.
32. Saman S, Coetzee WA, Opie LH. Inhibition by simulated ischemia or hypoxia of delayed afterdepolarizations provoked by cyclic AMP: Significance for ischemic and reperfusion arrhythmias. J Mol Cell Cardiol. 1988;20:91-95.
33. Bénitah J-P, Vassort G. Aldosterone upregulates Ca2+ current in adult rat cardiomyocytes. Circ Res. 1999;85:1139-1145. (Pubitemid 30430618)
34. Caballero R, Moreno I, González T, et al. Spironolactone and its main metabolite, canrenoic acid, block human ether-a-go-go-related gene channels. Circulation. 2003;107:889-895. (Pubitemid 36241049)
35. Bénitah J-P, Perrier E, Gómez AM, et al. Effects of aldosterone on transient outward K+ current density in rat ventricular myocytes. J Physiol. 2001;537:151-160. (Pubitemid 33076962)
36. Yuan S, Wohlfart B, Olsson SB, et al. The dispersion of repolarization in patients with ventricular tachycardia. A study using simultaneous monophasic action potential recordings from two sites in the right ventricle. Eur Heart J. 1995;16:68-76.
37. Anumonwo JMB, Lopatin AN. Cardiac strong inward rectifier potassium channels. J Mol Cell Cardiol. 2010;48:45-54.